2026-07-25 04:34:36
Latest Post
TANFAC Industries Reports Q1 FY27 Net Profit of ₹16.85 Crore; Operational Revenue Up 6.3% YoY to ₹187.18 Crore
New India Assurance Reports Q1 FY27 Net Loss of ₹243.94 Crore; Gross Written Premium Rises 2.9% YoY to ₹13,835 Crore
NTPC Consolidated Q1 FY27 Net Profit Rises 12.9% YoY to ₹6,896 Crore; Operational Revenue Up 7.8% at ₹50,741 Crore
Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore
Arihant Capital Markets Reports Q1 FY27 Net Profit of ₹21.49 Crore, Up 69.2% YoY; Operational Revenue Jumps 53.5%
Stock Report
Aurobindo receives 36th USFDA approval
Posted On : 2007-01-18 12:16:30( TIMEZONE : IST )
Aurobindo Pharma Ltd has announced that the Company has received one more approval from the US FDA for Amoxicillin Tablets for oral suspension 200mg and 400mg.
Amoxicillin Tablets for oral suspension is a Beta-lactam antibiotic used often in treating respiratory infections. With this approval the Company has its Amoxicillin approved by USFDA in four different formulations.
